---
# jekyll header
---
{% include header.html %}

<!-- ============BreadCrumb=============== -->

{% include container-start.html %}

<!-- ============CONTENT CONTENT=============== -->

<h2>
  ValueSets defined as part of this Implementation Guide:
</h2>

<h3>Value Sets</h3>
<table class="codes">
  <thead>
    <tr>
      <td>
        <b>Name</b>
      </td>
      <td>
        <b>Definition</b>
      </td>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="ValueSet-cimi-AnatomicalDirectionVS.html">AnatomicalDirectionVS</a></td>
      <td>Anatomical location or specimen further detailing directionality. Codes are from NCI</td>
    </tr>
    <tr>
      <td><a href="ValueSet-cimi-AnatomicalLocationVS.html">AnatomicalLocationVS</a></td>
      <td>Codes that describe normal and pathologic anatomic systems, regions, cavities, and spaces.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastCancerDetectionVS.html">BreastCancerDetectionVS</a></td>
      <td>Basis for cancer detection, from HL7 CDA® R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm Standard for Trial Use Release 3, October 2016, Volume 2 — Templates and Supporting Material.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastCancerMCategoryVS.html">BreastCancerMCategoryVS</a></td>
      <td>Codes that designate concepts describing Metastases category according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastCancerNCategorySuffixVS.html">BreastCancerNCategorySuffixVS</a></td>
      <td>Codes that designate concepts describing N-category suffixes according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastCancerNCategoryVS.html">BreastCancerNCategoryVS</a></td>
      <td>Codes that designate concepts describing breast clinical lymph node categories according to AJCC Cancer Staging Manual 8th Edition.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastCancerStageVS.html">BreastCancerStageVS</a></td>
      <td>Codes that designate concepts describing breast cancer stage group, according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastCancerTCategorySuffixVS.html">BreastCancerTCategorySuffixVS</a></td>
      <td>Codes that designate concepts describing T-category suffixes according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastCancerTCategoryVS.html">BreastCancerTCategoryVS</a></td>
      <td>Codes that designate concepts describing stages for Tumor category according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastCancerTypeVS.html">BreastCancerTypeVS</a></td>
      <td>Histologic types of breast cancer. Codes are drawn from ICD-O-3.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastSiteVS.html">BreastSiteVS</a></td>
      <td>Topography of the breast. Codes are drawn from ICD-O-3.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastSpecimenCollectionMethodVS.html">BreastSpecimenCollectionMethodVS</a></td>
      <td>The surgical method used to obtain the tissue sample.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-BreastSpecimenTypeVS.html">BreastSpecimenTypeVS</a></td>
      <td>The type of specimen obtained from the breast.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-shr-core-ClockDirectionVS.html">ClockDirectionVS</a></td>
      <td></td>
    </tr>
    <tr>
      <td><a href="ValueSet-cimi-ConditionCategoryVS.html">ConditionCategoryVS</a></td>
      <td></td>
    </tr>
    <tr>
      <td><a href="ValueSet-cimi-ConditionVS.html">ConditionVS</a></td>
      <td></td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-DegreeOfLymphaticInvolvementVS.html">DegreeOfLymphaticInvolvementVS</a></td>
      <td>Value set containing the degree of lymphatic involvement.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-cimi-DeltaFlagVS.html">DeltaFlagVS</a></td>
      <td></td>
    </tr>
    <tr>
      <td><a href="ValueSet-cimi-statement-DiagnosticServiceVS.html">DiagnosticServiceVS</a></td>
      <td>The type of laboratory service used in producing a laboratory result</td>
    </tr>
    <tr>
      <td><a href="ValueSet-cimi-ExceptionValueVS.html">ExceptionValueVS</a></td>
      <td>Reasons that a value associated with a test or other finding is missing. Extended set based on http://hl7.org/fhir/ValueSet/observation-valueabsentreason</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-HER2IHCMethodVS.html">HER2IHCMethodVS</a></td>
      <td>Value set containing methods of determining HER2 status by immunohistochemistry</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-HER2ISHMethodVS.html">HER2ISHMethodVS</a></td>
      <td>Value set containing In Situ Hybridization methods of determining HER2 status</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-HER2StatusVS.html">HER2StatusVS</a></td>
      <td>HER2 status overall result</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-HER2byIHCScoreVS.html">HER2byIHCScoreVS</a></td>
      <td>Value set containing possible scores resulting from determining HER2 status by immunohistochemistry. Based on LNC#LL4396-9 answer list.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-cimi-LateralityVS.html">LateralityVS</a></td>
      <td>Anatomical location or specimen further detailing the side(s) of interest. Codes are from NCI</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-LeftRightLateralityVS.html">LeftRightLateralityVS</a></td>
      <td>Simplified set of laterality codes indicating detailing the side(s) of interest. Codes are from NCI</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-LymphSystemSubdivisionVS.html">LymphSystemSubdivisionVS</a></td>
      <td>A lymph node area or nodal group; a subdivision of the entire lymphatic system. For breast cancer, this includes 5 areas: internal mammary lymph nodes, axillary lymph nodes level I, II, and III, and the supraclavicular lymph nodes.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-MammaprintRiskScoreInterpretationVS.html">MammaprintRiskScoreInterpretationVS</a></td>
      <td>Intepretation of Mammaprint Recurrence Score</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-MitoticCountScoreVS.html">MitoticCountScoreVS</a></td>
      <td>Value set containing the scores for Nottingham Histologic Score Mitotic Rate</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-MorphologyBehaviorVS.html">MorphologyBehaviorVS</a></td>
      <td>The morphologic behavior of the cancer. These are the suffix to the ICD-O-3 histologic type codes</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-NottinghamCombinedGradeVS.html">NottinghamCombinedGradeVS</a></td>
      <td></td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-NuclearGradeVS.html">NuclearGradeVS</a></td>
      <td>The nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. The nuclear grade is a part of overall tumor grade.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-NuclearPleomorphismScoreVS.html">NuclearPleomorphismScoreVS</a></td>
      <td>Value set containing the scores for nuclear pleomorphism.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-OncotypeDxDCISRiskScoreInterpretationVS.html">OncotypeDxDCISRiskScoreInterpretationVS</a></td>
      <td>Intepretation of OncotypeDX DCIS (Ductal Carcinoma In Situ) Recurrence Score</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-OncotypeDxInvasiveRiskScoreInterpretationVS.html">OncotypeDxInvasiveRiskScoreInterpretationVS</a></td>
      <td>Intepretation of OncotypeDX Recurrence Score for invasive cancers.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-PositiveNegativeEquivocalVS.html">PositiveNegativeEquivocalVS</a></td>
      <td>Interpretation of a test result as positive, negative or equivocal.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-PositiveNegativeVS.html">PositiveNegativeVS</a></td>
      <td>Value set containing the values positive and negative.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-cimi-PresenceContextVS.html">PresenceContextVS</a></td>
      <td>A code describing whether the finding in question is present, possible, suspected, etc.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-RecurrenceRiskScoreInterpretationVS.html">RecurrenceRiskScoreInterpretationVS</a></td>
      <td>Interpretations of risk as high, intermediate, or low. Answer set taken from LOINC LL3198-0</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-StageTimingPrefixVS.html">StageTimingPrefixVS</a></td>
      <td>When staging was done, relative to treatment events.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-StagingMethodVS.html">StagingMethodVS</a></td>
      <td>The methodology or standard used to do the staging.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-StainingIntensityVS.html">StainingIntensityVS</a></td>
      <td>Part of the Allred scoring, based on the intensity of that staining, on a scale of 0 (Negative) to 3 (Strong).</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-TubuleFormationScoreVS.html">TubuleFormationScoreVS</a></td>
      <td>Value set containing the extent (scope) of tubule formation.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-oncology-TumorMarginDescriptionVS.html">TumorMarginDescriptionVS</a></td>
      <td>Value set containing the descriptions of tumor margin.</td>
    </tr>
    <tr>
      <td><a href="ValueSet-shr-core-YesNoUnknownVS.html">YesNoUnknownVS</a></td>
      <td></td>
    </tr>
    <tr>
      <td><a href="ValueSet-shr-core-YesNoVS.html">YesNoVS</a></td>
      <td></td>
    </tr>
    
  </tbody>
</table>

<!-- ==============END CONTENT END CONTENT=================== -->

{% include container-end.html %}
{% include footer.html %}